Small interfering RNA inhibits hepatitis B virus replication in mice

Molecular Therapy

Volumn 8, Issue 5, 2003, Pages 769-776

  Giladi, Hilla ^a   Ketzinel Gilad, Mali ^a   Rivkin, Ludmila ^a   Felig, Yaakov ^a   Nussbaum, Ofer ^b   Galun, Eithan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b XTL Biopharmaceuticals Ltd Israel   (Israel)

Author keywords

Animal model; Antiviral therapy; HBV; Hydrodynamic injection; RNAi

Indexed keywords

ADEFOVIR DIPIVOXIL; DOUBLE STRANDED RNA; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; MEMBRANE ANTIGEN; MESSENGER RNA; NUCLEOSIDE DERIVATIVE; PLASMID VECTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHRONIC HEPATITIS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; GENE EXPRESSION; GENE LOCATION; GENE TARGETING; HEPATITIS B; HEPATITIS B VIRUS; IN VIVO STUDY; MAMMAL CELL; MOUSE; NONHUMAN; RNA SYNTHESIS; TISSUE DISTRIBUTION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; MAMMALIA;

EID: 0346873025     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00244-2     Document Type: Article

References (34)

1. Ganem, D., and Varmus, H. E. (1987). The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56: 651-693.
2. Lee, W. M. (1997). Hepatitis B virus infection. N. Engl. J. Med. 337: 1733-1745.
3. Lin, O. S., and Keeffe, E. B. (2001). Current treatment strategies for chronic hepatitis B and C. . Annu. Rev. Med. 52: 29-49.
4. Dienstag, J. L., et al. (2003). Durability of serologic response after lamivudine treatment of chronic hepatitis B.. Hepatology 37: 748-755.
5. Lai, C. L., et al. (2002). Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis 8 infection. Gastroenterology 123: 1831-1838.
6. Marcellin, P., et al. (2003). Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N. Engl. J. Med. 348: 808-816.
7. McManus, M. T., and Sharp, P. A. (2002). Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3: 737-747.
8. Hammond, S. M., Caudy, A. A., and Hannon, G. J. (2001). Post-transcriptional gene silencing by double-stranded RNA. Nat. Rev. Genet. 2: 110-119.
9. Elbashir, S. M., Lendeckel, W., and Tuschl, T. (2001). RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15: 188-200.
10. Zamore, P. D., Tuschl, T., Sharp, P. A., and Bartel, D. P. (2000). RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101: 25-33.
11. Brummelkamp, T. R., Bernards, R., and Agami, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553.
12. Gitlin, L., Karelsky, S., and Andino, R. (2002). Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418: 430-434.
13. Wilson, J. A., et al. (2003). RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. USA 100: 2783-2788.
14. Randall, G., Grakoui, A., and Rice, C. M. (2003). Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl. Acad. Sci. USA 100: 235-240.
15. Kapadia, S. B., Brideau-Andersen, A., and Chisari, F. V. (2003). Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA 100: 2014-2018.
16. Ge, Q., et al. (2003). RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. USA 100: 2718-2723.
17. Coburn, G. A., and Cullen, B. R. (2002). Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76: 9225-9231.
18. Capodici, I., Kariko, K., and Weissman, D. (2002). Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169: 5196-5201.
19. Surabhi, R. M., and Gaynor, R. B. (2002). RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type 1 replication. J. Virol. 76: 12963-12973.
20. Shlomai, A., and Shaul, Y. (2003). Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37: 764-770.
21. McCaffrey, A. P., et al. (2003). Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21: 639-644.
22. Sells, M. A., Chen, M. L., and Acs, G. (1987). Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84: 1005-1009.
23. Araki, K., et al. (1989). Expression and replication of hepatitis B virus genome in transgenic mice. Proc. Natl. Acad. Sci. USA 86: 207-211.
24. Chisari, F. V. (1995). Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology 22: 1316-1325.
25. Yang, P. L., Althage, A., Chung, J., and Chisari, F. V. (2002). Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 99: 13825-13830.
26. Suzuki, T., et al. (2003). Intravenous injection of naked plasmid DNA encoding hepatitis B virus (HBV) produces HBV and induces humaral immune response in mice. Biochem. Biophys. Res. Commun. 300: 784-788.
27. Zhang, G., Budker, V., and Wolff, J. A. (1999). High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10: 1735-1737.
28. Blum, H. E., Galun, E., Liang, T. J., von Weizsacker, F., and Wands, J. R. (1991). Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication.. J. Virol. 65: 1836-1842.
29. Seeger, C., and Mason, W. S. (2000). Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64: 51-68.
30. Duronio, V., Huber, B. E., and Jacobs, S. (1990). Partial down-regulation of protein kinase C reverses the growth inhibitory effect of phorbol esters on HepG2 cells. J. Cell. Physiol. 145: 381-389.
31. McCaffrey, A. P., et al. (2002). RNA interference in adult mice. Nature 418: 38-39.
32. Song, E., et al. (2003). RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9: 347-351.
33. Liu, F., Song, Y., and Liu, D. (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6: 1258-1266.
34. Ilan, E., et al. (1999). The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 29: 553-562.